NEW YORK, Nov. 8, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PXMD, APLT, THAR, OMIC, and BIOL.

InvestorsObserver (PRNewsfoto/InvestorsObserver)

To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.

  1. PXMD: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=PXMD&prnumber=110820234
  2. APLT: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=APLT&prnumber=110820234
  3. THAR: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=THAR&prnumber=110820234
  4. OMIC: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=OMIC&prnumber=110820234
  5. BIOL: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=BIOL&prnumber=110820234

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.

InvestorsObserver provides patented technology to some of the biggest names on Wall Street and creates world-class investing tools for the self-directed investor on Main Street. We have a wide range of tools to help investors make smarter decisions when investing in stocks or options.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-paxmedica-applied-therapeutics-tharimmune-singular-genomics-systems-or-biolase-301981583.html

SOURCE InvestorsObserver